Media Contact: Keith Hautala
LEXINGTON, Ky. (April 12, 2010) − The
University of Kentucky Markey Cancer Center has formed an
international partnership with its first "sister center," the Shanghai
First People's Hospital Comprehensive Cancer Center in Shanghai, China.
Dr. Mark Evers, director of the Markey Cancer Center, hailed the
partnership as an example of the type of international collaboration
needed among scientists and medical practitioners in the worldwide
effort to beat cancer. It also distinguishes the Markey Cancer Center
as not just the premier cancer center in Kentucky, but as a world-class
cancer treatment and research facility with global influence.
The relationship between the two centers was made official at a
signing ceremony held at the University of Kentucky April 2. At the
ceremony, representatives from both institutions signed a memorandum of
understanding outlining plans for cooperative initiatives in cancer
prevention and treatment, research collaboration and personnel
exchanges for training and education.
"This is yet another wonderful milestone for the Markey Cancer Center
and the University of Kentucky," Evers said. "This ceremony marks the
beginning of new collaborations and interactions with our sister
cancer center in Shanghai and demonstrates the enlarging global
influence of the Markey Cancer Center. We look forward to strengthening
our ties with our colleagues in China as we work together to identify
new and better treatment options for our cancer patients."
Evers signed the memorandum of understanding on behalf of UK, along
with UK Executive Vice President for Health Affairs Dr. Michael Karpf.
Signing on behalf of the Shanghai cancer center were Dr. Liwei Wang,
the center's director, and Dr. Guohua Liu, president of Shanghai First
"Cancer is a big issue, not just in China, but also in the United
States," Liu said. "The collaboration will help promote research and
patient care. It will be very significant in this respect."
Shanghai First People’s Hospital, affiliated with Shanghai Jiaotong
University, is one the largest major hospitals in the Shanghai
metropolitan area. Its cancer center has more than 43,000 outpatient
visits and over 5,700 cancer surgeries per year. Major research
interests are focused on gastrointestinal cancer, lung cancer and
"They have a very sophisticated center, and we already do research
collaboration with them," Karpf said. "I think this will further our
research efforts as much as it furthers their research efforts. We will
get new information and new knowledge out of this that will get
translated into action in Kentucky."